(Q38003453)

English

Studies on α-glucosidase inhibitors development: magic molecules for the treatment of carbohydrate mediated diseases.

scientific article published on July 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

22512574

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22512574%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 January 2020

title

Studies on α-glucosidase inhibitors development: magic molecules for the treatment of carbohydrate mediated diseases (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

22512574

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22512574%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 January 2020

author

N.S. Hari Narayana Moorthy

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

22512574

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22512574%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 January 2020

Maria J. Ramos

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

22512574

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22512574%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 January 2020

Pedro Alexandrino Fernandes

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

22512574

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22512574%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 January 2020

author name string

Moorthy NS

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

22512574

retrieved

26 August 2017

Ramos MJ

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

22512574

retrieved

26 August 2017

Fernandes PA

series ordinal

3

1 reference

stated in

Europe PubMed Central

26 August 2017

1 July 2012

1 reference

stated in

Europe PubMed Central

PubMed ID

22512574

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22512574%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 January 2020

published in

Mini-Reviews in Medicinal Chemistry

1 reference

stated in

Europe PubMed Central

PubMed ID

22512574

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22512574%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 January 2020

volume

12

1 reference

stated in

Europe PubMed Central

PubMed ID

22512574

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22512574%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 January 2020

issue

8

1 reference

stated in

Europe PubMed Central

PubMed ID

22512574

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22512574%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 January 2020

page(s)

713-720

1 reference

stated in

Europe PubMed Central

PubMed ID

22512574

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22512574%20AND%20SRC:MED&resulttype=core&format=json

(Q38003453)

Studies on α-glucosidase inhibitors development: magic molecules for the treatment of carbohydrate mediated diseases.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)